Impact of molecular diagnostics and targeted cancer therapy on patient outcomes (MODIFY): a retrospective study of the implementation of precision oncology
High‐throughput genomic analyses are being implemented in clinical practice. MODIFY is a retrospective study of the first introduction of genomic profiling and molecular tumor boards in the country of Luxembourg. The primary objective was to assess whether patients derived a clinical benefit by meas...
Saved in:
| Main Authors: | Michaël Dang, Anna Schritz, Nikolai Goncharenko, Guy Berchem |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-05-01
|
| Series: | Molecular Oncology |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/1878-0261.13785 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
PRECISION ONCOLOGY- BASIC TO BEDSIDE
by: Amit Verma
Published: (2022-08-01) -
The role of advanced diagnostics on precision medicine in hemato oncology
by: Befikad Mandefro, et al.
Published: (2025-08-01) -
Advancing precision oncology with AI-powered genomic analysis
by: Ruby Srivastava
Published: (2025-04-01) -
From Genomics to AI: Revolutionizing Precision Medicine in Oncology
by: Giulia Calvino, et al.
Published: (2025-06-01) -
Implementing somatic mutation testing in clinical setting: recommendations from a panel of experts
by: Vladmir Cláudio Cordeiro-de-Lima, et al.
Published: (2021-10-01)